03/30/2022
https://congress.gov...
"That's a no-go, that's a red line that we're not changing our position on."
"It’s cheaper to try and cure it, or at least manage it and delay it, than it is to deal with it."
"This is our most expensive disease."
"To be able to do what we’ve done, a fivefold increase in Alzheimer’s and dementia research is a very special thing."